Karyopharm Therapeutics Correlations

KPTI Stock

USD 4.12 0.08 1.90%

The current 90-days correlation between Karyopharm Therapeutics and X4 Pharmaceuticals is 0.1 (i.e., Average diversification). The correlation of Karyopharm Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Karyopharm Therapeutics Correlation With Market

Modest diversification

The correlation between Karyopharm Therapeutics and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Karyopharm Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Karyopharm Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.

Moving together with Karyopharm Stock

0.74	DMAC	DiaMedica Therapeutics	Pair Corr
0.86	DNLI	Denali Therapeutics	Pair Corr
0.76	DNTH	Dianthus Therapeutics	Pair Corr
0.76	VERV	Verve Therapeutics Buyout Trend	Pair Corr
0.67	VERA	Vera Therapeutics Trending	Pair Corr
0.72	DSGN	Design Therapeutics	Pair Corr
0.71	DTIL	Precision BioSciences	Pair Corr
0.69	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.64	VKTX	Viking Therapeutics	Pair Corr
0.68	VRAX	Virax Biolabs Group	Pair Corr
0.62	VRDN	Viridian Therapeutics	Pair Corr
0.64	VTRS	Viatris Aggressive Push	Pair Corr

Moving against Karyopharm Stock

0.31

KTTAW

Pasithea Therapeutics

Pair Corr

Related Correlations Analysis

	XFOR	HOOK	MREO	GRTX	ABOS	CTMX	NUVB	NLTX	ASMB	LYRA
XFOR		-0.14	0.25	0.0	0.82	-0.65	-0.48	0.0	-0.34	0.89	XFOR
HOOK	-0.14		0.25	0.0	0.18	0.64	0.43	0.0	0.87	0.22	HOOK
MREO	0.25	0.25		0.0	0.47	-0.12	0.42	0.0	0.32	0.44	MREO
GRTX	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	GRTX
ABOS	0.82	0.18	0.47	0.0		-0.38	-0.09	0.0	0.01	0.9	ABOS
CTMX	-0.65	0.64	-0.12	0.0	-0.38		0.55	0.0	0.71	-0.42	CTMX
NUVB	-0.48	0.43	0.42	0.0	-0.09	0.55		0.0	0.68	-0.22	NUVB
NLTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	NLTX
ASMB	-0.34	0.87	0.32	0.0	0.01	0.71	0.68	0.0		0.01	ASMB
LYRA	0.89	0.22	0.44	0.0	0.9	-0.42	-0.22	0.0	0.01		LYRA
	XFOR	HOOK	MREO	GRTX	ABOS	CTMX	NUVB	NLTX	ASMB	LYRA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LYRA	+ 0.9	ABOS
LYRA	+ 0.89	XFOR
ASMB	+ 0.87	HOOK
ABOS	+ 0.82	XFOR
ASMB	+ 0.71	CTMX
ASMB	+ 0.68	NUVB

High negative correlations

CTMX	- 0.65	XFOR
NUVB	- 0.48	XFOR
LYRA	- 0.42	CTMX
CTMX	- 0.38	ABOS
ASMB	- 0.34	XFOR
LYRA	- 0.22	NUVB

Risk-Adjusted Indicators

There is a big difference between Karyopharm Stock performing well and Karyopharm Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Karyopharm Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
XFOR	4.83	(1.69)	0.00	(1.67)	0.00	0.00	8.31	(12.20)	27.97
HOOK	5.19	0.38	0.06	0.30	5.50	(6.46)	13.10	(8.70)	52.09
MREO	3.38	(0.07)	0.00	(0.10)	0.00	0.00	7.33	(7.20)	19.17
GRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ABOS	3.82	(0.22)	0.00	(0.27)	0.00	0.00	7.84	(7.62)	25.32
CTMX	8.02	3.14	0.41	0.99	5.62	(11.31)	15.09	(11.48)	145.00
NUVB	3.66	0.27	0.06	0.22	4.33	(4.26)	8.43	(7.26)	33.99
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ASMB	3.35	0.24	0.06	0.18	3.87	(3.78)	7.33	(6.08)	34.50
LYRA	4.81	(0.88)	0.00	(2.08)	0.00	0.00	14.12	(10.28)	33.21

Karyopharm Therapeutics Corporate Management

Reshma MD	Chief VP	Profile
Kristin Abate	Chief VP	Profile
James JD	Chief Officer	Profile
Lisa DiPaolo	Executive Officer	Profile
Sohanya MBA	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC